Kathryn Acheson has been providing strategic consulting services to biopharma companies since 2020, when she joined the Blue Matter team in Zurich, before transferring to the New York office in 2024. Prior to launching her consulting career, her work experience included Novartis, the Wellcome Trust, and GSK. Kathryn earned a DPhil in Cardiovascular Pharmacology from the University of Oxford.